• ANDAPharm repeat violations lead to FDA action fiercepharma
    March 08, 2019
    The FDA has issued a warning letter to a Florida CMO that it says has dirty equipment, poor storage methods and questionable record keeping about whether drugs were effective.
PharmaSources Customer Service